These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 7843686

  • 21. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T, Takamura T, Nagai Y, Bando Y, Usuda R.
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C, Hieronimus S, Ferrari P, Thomas P, Lebrun C.
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
    Lazar D, Weintrob N, Abramov N, Assa S, Bloch K, Ofan R, Ben-Zaken H, Vardi P.
    Harefuah; 1998 May 01; 134(9):678-81, 750. PubMed ID: 10909610
    [Abstract] [Full Text] [Related]

  • 30. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B, Zimmy S, Schatz H, Pfohl M.
    Med Klin (Munich); 2003 Feb 15; 98(2):67-71. PubMed ID: 12601530
    [Abstract] [Full Text] [Related]

  • 31. Dual-parameter model for prediction of type I diabetes mellitus.
    Eisenbarth GS, Gianani R, Yu L, Pietropaolo M, Verge CF, Chase HP, Redondo MJ, Colman P, Harrison L, Jackson R.
    Proc Assoc Am Physicians; 1998 Feb 15; 110(2):126-35. PubMed ID: 9542768
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC, Levy-Marchal C.
    Diabetes Metab; 1997 Apr 15; 23(2):155-60. PubMed ID: 9137905
    [Abstract] [Full Text] [Related]

  • 35. Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children.
    Mendoza-Morfín F, Curiel-Pérez MO, Cárdenas-Tirado H, Montero-González P, Gutiérrez-Avila C, Bravo-Ríos LE, Cárdenas-Cornejo I, Normandía-Almeida MA.
    Rev Invest Clin; 2000 Apr 15; 52(4):427-31. PubMed ID: 11061105
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. GAD antigen and its significance in type I diabetes.
    Hawa MI, Leslie RD.
    J Endocrinol Invest; 2002 Apr 15; 25(7):576. PubMed ID: 12150328
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. What is the best way to predict IDDM?
    Palmer JP.
    Lancet; 1994 Jun 04; 343(8910):1377-8. PubMed ID: 7910879
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.